In subsequent studies, other groups (Gillespie et al., 1997; Wang et al., 2004) demonstrated that CTR, mostly the isoform 2, was expressed in tumor samples and cell lines and that a decreased CTR expression was observed in advanced tumors with lymph node metastases and lymphatic invasion. This evidence concerns the gene CALCR and neoplasm.